Outreach screening of drug users for cirrhosis with transient elastography

Addiction

Volumn 106, Issue 5, 2011, Pages 970-976

  Moessner, Belinda K ^a   Jørgensen, Tina R ^b   Skamling, Merete ^c   Vyberg, Mogens ^d   Junker, Peter ^a   Pedersen, Court ^a   Christensen, Peer B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Treatment Center Odense   (Denmark)

^c Treatment Center Svendborg   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cirrhosis; Hepatitis C; Hyaluronic acid; Screening; Street based; Transient elastography

Indexed keywords

BIOLOGICAL MARKER; HYALURONIC ACID;

ADULT; ARTICLE; BIOPSY; BLOOD; CROSS-SECTIONAL STUDY; DENMARK; ELASTOGRAPHY; EVALUATION; FEMALE; FIBROSIS; HEPATITIS C; HUMAN; LIVER; LIVER CIRRHOSIS; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CROSS-SECTIONAL STUDIES; DENMARK; ELASTICITY IMAGING TECHNIQUES; FEMALE; FIBROSIS; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; LIVER; LIVER CIRRHOSIS; MALE; MASS SCREENING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79953790732     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03246.x     Document Type: Article

References (38)

1. Christensen P. B., Krarup H. B., Moller A., Laursen A. L., Kjaer M. S., Orholm M. etal. Liver biopsy performance and histological findings among patients with chronic viral hepatitis: a Danish database study. Scand J Infect Dis 2007; 39: 245-9.
2. Castera L., Vergniol J., Foucher J., Le B. B., Chanteloup E., Haaser M. etal. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
3. Colletta C., Smirne C., Fabris C., Toniutto P., Rapetti R., Minisini R. etal. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-45.
4. de Ledinghen V., Douvin C., Kettaneh A., Ziol M., Roulot D., Marcellin P. etal. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006; 41: 175-9.
5. Foucher J., Chanteloup E., Vergniol J., Castera L., Le B. B., Adhoute X. etal. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.
6. Sandrin L., Fourquet B., Hasquenoph J. M., Yon S., Fournier C., Mal F. etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
7. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F. etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
8. Yoshioka K., Kawabe N., Hashimoto S. Transient elastography: applications and limitations. Hepatol Res 2008; 38: 1063-8.
9. Laurent T. C., Fraser J. R. Hyaluronan. FASEB J 1992; 6: 2397-404.
10. Mehta P., Ploutz-Snyder R., Nandi J., Rawlins S. R., Sanderson S. O., Levine R. A. Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C. Am J Gastroenterol 2008; 103: 928-36.
11. Christensen P. B., Krarup H. B., Niesters H. G., Norder H., Georgsen J. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol 2000; 16: 1043-9.
12. Fuglsang T., Fouchard J. R., Ege P. P. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen]. Ugeskr Laeger 2000; 162: 3860-4.
13. Moessner B., Jørgensen T., Skamling M., Georgsen J., Pedersen C., Christensen P. B. Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users. J Med Virol 2010; 82: 1635-9.
14. Mehta S. H., Genberg B. L., Astemborski J., Kavasery R., Kirk G. D., Vlahov D. etal. Limited uptake of hepatitis C treatment among injection drug users. J Commun Health 2008; 33: 126-33.
15. Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-47.
16. Takeda T., Yasuda T., Nakayama Y., Nakaya M., Kimura M., Yamashita M. etal. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 2006; 12: 7768-73.
17. Krarup H. B., Drewes A. M., Madsen P. H. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest 1998; 58: 415-22.
18. Carrion J. A., Navasa M., Bosch J., Bruguera M., Gilabert R., Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791-8.
19. Coco B., Oliveri F., Maina A. M., Ciccorossi P., Sacco R., Colombatto P. etal. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14: 360-9.
20. Fraquelli M., Rigamonti C., Casazza G., Conte D., Donato M. F., Ronchi G. etal. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.
21. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-93.
22. Arena U., Vizzutti F., Abraldes J. G., Corti G., Stasi C., Moscarella S. etal. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57: 1288-93.
23. Foucher J., Reiller B., Jullien V., Leal F., di Cesare E. S., Merrouche W. etal. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study. J Viral Hepatol 2009; 16: 121-31.
24. Christensen P. B., Kringsholm B., Banner J., Thomsen J. L., Cowan S., Stein G. F. etal. Surveillance of HIV and viral hepatitis by analysis of samples from drug related deaths. Eur J Epidemiol 2006; 21: 383-7.
25. Guechot J., Laudat A., Loria A., Serfaty L., Poupon R., Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42: 558-63.
26. McHutchison J. G., Blatt L. M., de Medina M., Craig J. R., Conrad A., Schiff E. R. etal. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000; 15: 945-51.
27. Lebray P., Fedchuk L., Varaut A., Ingiliz P., Ngo Y., Munteanu M. etal. Clinically significant variability of liver stiffness measurements alters short-term follow-up of patients with chronic liver disease. J Hepatol 2010; 52: S165.
28. Colombo S., Belloli L., Buonocore M., Jamoletti C., Zaccanelli M., Badia E. etal. True normal liver stiffness measurement (LSM) and its determinants. Hepatology 2009; 50: 741A-2A.
29. Mederacke I., Wursthorn K., Kirschner J., Rifai K., Manns M. P., Wedemeyer H. etal. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009; 29: 1500-6.
30. Millonig G., Friedrich S., Adolf S., Fonouni H., Golriz M., Mehrabi A. etal. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-10.
31. Pozzoni P., Prati D., Berzuini A., Gerosa A., Canovi C., Molteni E. etal. Liver stiffness values measured by transient elastography are increased in patients with acutely decompensated heart failure. J Hepatology 2009; 50: S87.
32. Barnett A. G., van der Pols J. C., Dobson A. J. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005; 34: 215-20.
33. Roulot D., Czernichow S., Le C. H., Costes J. L., Vergnaud A. C., Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-13.
34. Vispo E., Barreiro P., Del Valle J., Maida I., de Ledinghen V., Quereda C. etal. Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation. Antivir Ther 2009; 14: 187-93.
35. Bialek S. R., Terrault N. A. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006; 10: 697-715.
36. Hu S. X., Kyulo N. L., Xia V. W., Hillebrand D. J., Hu K. Q. Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients. J Clin Gastroenterol 2009; 43: 758-64.
37. Massard J., Ratziu V., Thabut D., Moussalli J., Lebray P., Benhamou Y. etal. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 2006; 44: S19-S24.
38. Monto A., Patel K., Bostrom A., Pianko S., Pockros P., McHutchison J. G. etal. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004; 39: 826-34.